The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Forus; GlaxoSmithKline; Roche
Research Funding - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Roche
Safety and clinical activity of belantamab mafodotin with pembrolizumab in patients with relapsed/refractory multiple myeloma (RRMM): DREAMM-4 Study.
 
Attaya Suvannasankha
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Regeneron; Sutro Biopharma
Patents, Royalties, Other Intellectual Property - PTH analog in cancer cachexia (VA Medical affairs: filer)
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Suzanne Trudel
No Relationships to Disclose
 
Katja Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Christian Koenecke
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; EUSA Pharma; GlaxoSmithKline; Janssen; Kite/Gilead; Medigene; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; EUSA Pharma; GlaxoSmithKline; Janssen; Kite/Gilead; Medigene; Novartis; Roche; Sanofi; Takeda
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Secura Bio
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Aránzazu Alonso Alonso
No Relationships to Disclose
 
Natalie Scott Callander
Research Funding - Cellectar
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Nishitha Reddy
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Shawn Hakim
No Relationships to Disclose
 
Nashita Patel
Employment - Abbvie; GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Danae Williams
Employment - GlaxoSmithKline
 
Roxanne C. Jewell
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Alcon; GlaxoSmithKline; Novartis
 
Xiangdong Zhou
Employment - GlaxoSmithKline
 
Ira V. Gupta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline